Association of immune-inflammatory biomarkers during pregnancy and the postpartum period with postpartum depression symptoms: A cross-sectional and longitudinal retrospective analysis
Kaipeng Xie , Shengyuan Jiang , Yixiao Wang , Haiyan Chen , Xiaoli Wu , Bo Xu
{"title":"Association of immune-inflammatory biomarkers during pregnancy and the postpartum period with postpartum depression symptoms: A cross-sectional and longitudinal retrospective analysis","authors":"Kaipeng Xie , Shengyuan Jiang , Yixiao Wang , Haiyan Chen , Xiaoli Wu , Bo Xu","doi":"10.1016/j.bbi.2025.05.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Postpartum depression (PPD) is characterized by feelings of sadness, hopelessness, and disinterest in daily activities, leading to detrimental effects on both maternal and child well-being. We aimed to investigate the associations between blood immune-inflammatory biomarkers during pregnancy and the postpartum period and the risk of PPD.</div></div><div><h3>Methods</h3><div>In this study, we included postpartum women who underwent routine blood tests during second and third trimester visits as well as postpartum reviews. Immune-inflammatory biomarkers were assessed at three time points: neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammatory index (SII), systemic inflammatory response index (SIRI), and pan-immune-inflammatory value (PIV). PPD symptoms were assessed at five to eight weeks postpartum using the Edinburgh Postnatal Depression Scale (EPDS). Multivariable logistic regression, restricted cubic spline (RCS) regression, and subgroup and sensitivity analyses were used to examine the relationships between immune-inflammatory biomarkers and PPD symptoms.</div></div><div><h3>Results</h3><div>Of the 17,500 women eligible for analysis, 2,576 (14.72 %) exhibited PPD symptoms. During the postpartum period, maternal lymphocyte count was associated with decreased odds of PPD symptoms (OR = 0.86, 95 % CI: [0.80, 0.93]), whereas NLR, PLR, and SII were associated with increased odds of PPD symptoms after Bonferroni correction (OR = 1.19, 95 % CI: [1.06, 1.34]; OR = 1.40, 95 % CI: [1.21, 1.61]; OR = 1.18, 95 % CI: [1.07, 1.30], respectively). The relationships showed significant linear trends (all <em>P</em> for nonlinear > 0.05). Subgroup analyses demonstrated that cesarean delivery could modify the association between NLR and PPD symptoms (<em>P</em> for interaction = 0.034). The significant association between NLR and PPD symptoms was observed only in women without cesarean delivery (OR = 1.31, 95 % CI: [1.13, 1.52]). Sensitivity analyses showed that the main findings remained robust.</div></div><div><h3>Conclusions</h3><div>Our findings suggest that lymphocyte count, NLR, PLR, and SII during the postpartum period are independent risk factors for PPD symptoms. Monitoring these biomarkers could aid in clinical decision-making and the implementation of effective PPD management strategies.</div></div>","PeriodicalId":9199,"journal":{"name":"Brain, Behavior, and Immunity","volume":"129 ","pages":"Pages 42-51"},"PeriodicalIF":8.8000,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain, Behavior, and Immunity","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0889159125001928","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Postpartum depression (PPD) is characterized by feelings of sadness, hopelessness, and disinterest in daily activities, leading to detrimental effects on both maternal and child well-being. We aimed to investigate the associations between blood immune-inflammatory biomarkers during pregnancy and the postpartum period and the risk of PPD.
Methods
In this study, we included postpartum women who underwent routine blood tests during second and third trimester visits as well as postpartum reviews. Immune-inflammatory biomarkers were assessed at three time points: neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammatory index (SII), systemic inflammatory response index (SIRI), and pan-immune-inflammatory value (PIV). PPD symptoms were assessed at five to eight weeks postpartum using the Edinburgh Postnatal Depression Scale (EPDS). Multivariable logistic regression, restricted cubic spline (RCS) regression, and subgroup and sensitivity analyses were used to examine the relationships between immune-inflammatory biomarkers and PPD symptoms.
Results
Of the 17,500 women eligible for analysis, 2,576 (14.72 %) exhibited PPD symptoms. During the postpartum period, maternal lymphocyte count was associated with decreased odds of PPD symptoms (OR = 0.86, 95 % CI: [0.80, 0.93]), whereas NLR, PLR, and SII were associated with increased odds of PPD symptoms after Bonferroni correction (OR = 1.19, 95 % CI: [1.06, 1.34]; OR = 1.40, 95 % CI: [1.21, 1.61]; OR = 1.18, 95 % CI: [1.07, 1.30], respectively). The relationships showed significant linear trends (all P for nonlinear > 0.05). Subgroup analyses demonstrated that cesarean delivery could modify the association between NLR and PPD symptoms (P for interaction = 0.034). The significant association between NLR and PPD symptoms was observed only in women without cesarean delivery (OR = 1.31, 95 % CI: [1.13, 1.52]). Sensitivity analyses showed that the main findings remained robust.
Conclusions
Our findings suggest that lymphocyte count, NLR, PLR, and SII during the postpartum period are independent risk factors for PPD symptoms. Monitoring these biomarkers could aid in clinical decision-making and the implementation of effective PPD management strategies.
期刊介绍:
Established in 1987, Brain, Behavior, and Immunity proudly serves as the official journal of the Psychoneuroimmunology Research Society (PNIRS). This pioneering journal is dedicated to publishing peer-reviewed basic, experimental, and clinical studies that explore the intricate interactions among behavioral, neural, endocrine, and immune systems in both humans and animals.
As an international and interdisciplinary platform, Brain, Behavior, and Immunity focuses on original research spanning neuroscience, immunology, integrative physiology, behavioral biology, psychiatry, psychology, and clinical medicine. The journal is inclusive of research conducted at various levels, including molecular, cellular, social, and whole organism perspectives. With a commitment to efficiency, the journal facilitates online submission and review, ensuring timely publication of experimental results. Manuscripts typically undergo peer review and are returned to authors within 30 days of submission. It's worth noting that Brain, Behavior, and Immunity, published eight times a year, does not impose submission fees or page charges, fostering an open and accessible platform for scientific discourse.